Exacerbating and reversing lysosomal storage diseases: from yeast to humans
Lysosomal storage diseases (LSDs) arise from monogenic deficiencies in lysosomal proteins and pathways and are characterized by a tissue-wide accumulation of a vast variety of macromolecules, normally specific to each genetic lesion. Strategies for treatment of LSDs commonly depend on reduction of t...
Main Authors: | Tamayanthi Rajakumar, Andrew B. Munkacsi, Stephen L. Sturley |
---|---|
Format: | Article |
Language: | English |
Published: |
Shared Science Publishers OG
2017-08-01
|
Series: | Microbial Cell |
Subjects: | |
Online Access: | http://microbialcell.com/researcharticles/exacerbating-and-reversing-lysosomal-storage-diseases-from-yeast-to-humans/ |
Similar Items
-
Niemann Pick disease: a rare lysosomal storage disease
by: Gopen Kumar Kundu, et al.
Published: (2023-01-01) -
Lysosomal membrane glycoproteins bind cholesterol and contribute to lysosomal cholesterol export
by: Jian Li, et al.
Published: (2016-09-01) -
Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity
by: Stephen L. Sturley, et al.
Published: (2020-07-01) -
Lyso-IP: Uncovering Pathogenic Mechanisms of Lysosomal Dysfunction
by: Chase Chen, et al.
Published: (2022-04-01) -
Secondary Mitochondrial Dysfunction as a Cause of Neurodegenerative Dysfunction in Lysosomal Storage Diseases and an Overview of Potential Therapies
by: Karolina M. Stepien, et al.
Published: (2022-09-01)